When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SD - Adaptimmune doubles after #ASCO20 update on Phase 1 trial
SandRidge Energy Inc.
Adaptimmune Thereapeutics (NASDAQ:ADAP) shares soar after data from ADP-A2M4 Phase 1 trial was presented at at the American Society for Clinical Oncology (OTC:ASCO) Annual Meeting, showing durability and responses in synovial sarcoma. Data also indicated a new response in a lung cancer patient.
More news on: Adaptimmune Therapeutics plc, Airscooter Corp, SandRidge Energy, Inc., Stocks on the move,